KRISTIAN LUONG: Open Payments
NPI 1962076448 · SAN DIEGO, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$928 in 29 payments from 13 companies in 2025. Trend: 2023 $439 · 2024 $1,539 · 2025 $928
Food & beverage: $928
| Company | Payments | Amount |
|---|---|---|
| Incyte Corporation | 3 | $292 |
| Regeneron Healthcare Solutions, Inc. | 2 | $144 |
| ABBVIE INC. | 5 | $82 |
| Organon LLC | 5 | $74 |
| Novartis Pharmaceuticals Corporation | 1 | $69 |
| Lilly USA, LLC | 3 | $67 |
| Janssen Biotech, Inc. | 3 | $58 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $32 |
| LEO Pharma Inc. | 1 | $30 |
| UCB, Inc. | 1 | $24 |
Products named: OPZELURA, LIBTAYO, RINVOQ, TREMFYA, EBGLYSS, DUPIXENT, SPEVIGO, ADBRY.
Industry payments across CA — which companies pay providers there.
